Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
type: Article
item type: journalArticle
is part of: Hypertension
authors: Person
  surname: Meylan
  given name: S.
authors: Person
  surname: Livio
  given name: F.
authors: Person
  surname: Foerster
  given name: M.
authors: Person
  surname: Genoud
  given name: P. J.
authors: Person
  surname: Marguet
  given name: F.
authors: Person
  surname: Wuerzner
  given name: G.
authors: Person
  surname: Center
  given name: Chuv Covid Vaccination
subject: *COVID-19 Vaccines/administration & dosage/adverse effects
subject: *Hypertension/diagnosis/epidemiology/etiology
subject: Aged
subject: BNT162 Vaccine
subject: Blood Pressure Determination/methods/psychology
subject: COVID-19/epidemiology/*prevention & control/psychology
subject: Causality
subject: Female
subject: Humans
subject: Male
subject: Needs Assessment
subject: Psychology
subject: Risk Factors
subject: SARS-CoV-2
subject: Switzerland/epidemiology
subject: Symptom Assessment/methods
subject: Vaccination/methods/psychology
subject: headache
subject: hypertension
subject: vaccines
subject: vital signs
date: 2021-03-26
pages: e56-e57
coverage: 33764160

Hypertension
type: Journal
volume: 77
number: 6
identifier: DOI 10.1161/HYPERTENSIONAHA.121.17316
identifier: ISSN 1524-4563 (Electronic) 0194-911X (Print) 0194-911X (Linking)